Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (141-150 of 261) with videos related to

Pageof 27
Sort By:
FEBS Letters|October 2, 1995
Cloning and sequencing of a human thioredoxin reductaseP Y Gasdaska, J R Gasdaska, S Cochran, et al.
Genomics|October 15, 1996
Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissueJ R Gasdaska, P Y Gasdaska, A Gallegos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.
Cancer Research|November 26, 1997
Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivoA Baker, C M Payne, M M Briehl, et al.
Research Communications in Chemical Pathology and Pharmacology|April 1, 1981
Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against adriamycin induced skin ulcers in the ratB A Svingen, G Powis, P L Appel, et al.
Biochemical and Biophysical Research Communications|June 14, 2003
Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cellsB Husbeck, D E Stringer, E W Gerner, et al.
Cancer Treatment Reports|February 1, 1982
Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitolR T Eagan, M M Ames, G Powis, et al.
Oncology Research|January 1, 1997
Redox active disulfides: the thioredoxin system as a drug targetD L Kirkpatrick, G Ehrmantraut, S Stettner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dogJ I Brodfuehrer, T J Wilke, D H Kinder, et al.
Organic Letters|May 18, 2000
A versatile approach to PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3 from L-(-)-quebrachitolL Qiao, Y Hu, F Nan, et al.
Pageof 27

Showing results (141-150 of 261) with videos related to

Sort By:
Pageof 27
FEBS Letters|October 2, 1995
Cloning and sequencing of a human thioredoxin reductaseP Y Gasdaska, J R Gasdaska, S Cochran, et al.
Genomics|October 15, 1996
Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissueJ R Gasdaska, P Y Gasdaska, A Gallegos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patientsG Powis, P Reece, D L Ahmann, et al.
Cancer Research|November 26, 1997
Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivoA Baker, C M Payne, M M Briehl, et al.
Research Communications in Chemical Pathology and Pharmacology|April 1, 1981
Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against adriamycin induced skin ulcers in the ratB A Svingen, G Powis, P L Appel, et al.
Biochemical and Biophysical Research Communications|June 14, 2003
Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cellsB Husbeck, D E Stringer, E W Gerner, et al.
Cancer Treatment Reports|February 1, 1982
Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitolR T Eagan, M M Ames, G Powis, et al.
Oncology Research|January 1, 1997
Redox active disulfides: the thioredoxin system as a drug targetD L Kirkpatrick, G Ehrmantraut, S Stettner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dogJ I Brodfuehrer, T J Wilke, D H Kinder, et al.
Organic Letters|May 18, 2000
A versatile approach to PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3 from L-(-)-quebrachitolL Qiao, Y Hu, F Nan, et al.
Pageof 27